Episode Details

The Pentagon’s new testosterone screening policy for troops over thirty, spearheaded by Defense Secretary Pete Hegseth, aims to boost combat readiness—but it’s sparking controversy. While younger service members can opt in, older ones face annual checks, following a Navy SEALs scandal and a tragic 2022 training death that exposed widespread use of performance-enhancing hormones. Critics, including lawmakers and veterans, argue the focus is misplaced and call for broader hormone testing to address infertility in both genders. Meanwhile, the FDA weighs loosening testosterone prescription rules, fueling debate over its use for anti-aging and performance—despite medical skepticism. This move comes amid wider military health reforms, including vaccine mandates, signaling a new era of performance optimization—raising questions about fairness, science, and who’s really being served.

Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/d85e7bce6696302c